Tagged Agouron Pharmaceuticals

ECJC client ImmunoGenetix announces Richard Ogden, PhD, as new head of Scientific Advisory Board

Lenexa Kan. Dr. Ogden joined Agouron Pharmaceuticals, Inc. as a founding scientist at its inception in 1984, where he held positions of Group Leader of Medicinal Chemistry, Principal Scientist, and Senior Director of Scientific Development. He was a team member in the HIV project which led to the discovery and development of Nelfinavir (ViraceptĀ®).

Read more